Other News To Note
Altor BioScience Corp., of Miramar, Fla., and the Melanoma Research Alliance (MRA) will jointly sponsor a University of Washington study of Altor's IL-15 superagonist, ALT-803, against metastatic melanoma. MRA selected the project under its Academic-Industry Partnership grant program.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST